NEW YORK (GenomeWeb News) – Advanced Biological Laboratories has reached cross-license and strategic alliance agreements with Luxembourg-based Evivar, Melbourne, Australia-based ABL said today.

The companies have agreed to develop and commercialize their products, including ABL's TherapyEdge and Evivar's SeqHepB system, for use in management and treatment of HIV and Hepatitis B.